Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Prostate Cancer, mHSPC

Silke Gillessen

MD

🏢Oncology Institute of Southern Switzerland (IOSI)🌐Switzerland

Head of Department of Medical Oncology and Head of Prostate Cancer Program

52
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Silke Gillessen is a prostate cancer specialist who has contributed to PEACE-1 and other pivotal mHSPC trials examining triplet therapy combinations. She is chair of the Advanced Prostate Cancer Consensus Conference (APCCC) which convenes global experts to provide guidance on controversial treatment decisions in mHSPC and CRPC. Her research focuses on treatment sequencing, patient stratification, and quality of life in advanced prostate cancer. Gillessen has been instrumental in developing international consensus recommendations for mHSPC management.

Share:

🧪Research Fields 研究领域

mHSPC triplet therapy
PEACE-1 trial
darolutamide ARASENS
mHSPC treatment selection
advanced prostate cancer staging

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Silke Gillessen 的研究动态

Follow Silke Gillessen's research updates

留下邮箱,当我们发布与 Silke Gillessen(Oncology Institute of Southern Switzerland (IOSI))相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment